ResMed (RMD)
(Delayed Data from NYSE)
$213.26 USD
+1.68 (0.79%)
Updated May 24, 2024 04:00 PM ET
After-Market: $213.21 -0.05 (-0.02%) 6:40 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
ResMed Inc. [RMD]
Reports for Purchase
Showing records 141 - 160 ( 526 total )
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Supply Chain Constraints Remain Frustrating
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
PHG Remediation Timeline Again Extended
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Additonal FDA Actions on the PHG Recall
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department